Clinical Trial Details
| Trial ID: | L6394 |
| Source ID: | NCT02446028 |
| Associated Drug: | Biod-531 |
| Title: | A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes |
| Acronym: | |
| Status: | SUSPENDED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus |
| Interventions: | DRUG: BIOD-531|DRUG: Humalog® Mix 75/25 |
| Outcome Measures: | Primary: Change in HbA1c, 18 weeks | Secondary: Postprandial glucose excursions, 18 weeks|Change in weight, 18 weeks|Hypoglycemic event rates, 18 weeks |
| Sponsor/Collaborators: | Sponsor: Biodel |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 13 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2015-05 |
| Completion Date: | 2016-05 |
| Results First Posted: | |
| Last Update Posted: | 2016-04-07 |
| Locations: | Meridien Research, Bradenton, Florida, 34208, United States|Endocrine Research Solutions, Roswell, Georgia, 30076, United States|Cedar Crosse Research Center, Chicago, Illinois, 60607, United States|Springfield Diabetes and Endocrine Center, Springfield, Illinois, 62711, United States|Diabetes and Endocrinology Consultants, Morehead City, North Carolina, 28557, United States|Clinical Trials of Texas, San Antonio, Texas, 78229, United States|Ranier Clinical Research Center, Renton, Washington, 98057, United States |
| URL: | https://clinicaltrials.gov/show/NCT02446028 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|